AMLX
Price
$13.48
Change
-$0.01 (-0.07%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
1.44B
29 days until earnings call
CTMX
Price
$3.37
Change
+$0.04 (+1.20%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
549.16M
29 days until earnings call
Interact to see
Advertisement

AMLX vs CTMX

Header iconAMLX vs CTMX Comparison
Open Charts AMLX vs CTMXBanner chart's image
Amylyx Pharmaceuticals
Price$13.48
Change-$0.01 (-0.07%)
Volume$38.63K
Capitalization1.44B
CytomX Therapeutics
Price$3.37
Change+$0.04 (+1.20%)
Volume$56.51K
Capitalization549.16M
AMLX vs CTMX Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. CTMX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and CTMX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (AMLX: $13.49 vs. CTMX: $3.33)
Brand notoriety: AMLX and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 106% vs. CTMX: 74%
Market capitalization -- AMLX: $1.44B vs. CTMX: $549.16M
AMLX [@Biotechnology] is valued at $1.44B. CTMX’s [@Biotechnology] market capitalization is $549.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 1 green, 4 red.
According to our system of comparison, CTMX is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while CTMX’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 3 bearish.
  • CTMX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMLX and CTMX are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а -0.74% price change this week, while CTMX (@Biotechnology) price change was +4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

CTMX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.44B) has a higher market cap than CTMX($549M). CTMX has higher P/E ratio than AMLX: CTMX (6.66) vs AMLX (2.69). AMLX YTD gains are higher at: 256.878 vs. CTMX (223.301). CTMX has higher annual earnings (EBITDA): 44.7M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. CTMX (158M). AMLX has less debt than CTMX: AMLX (5.96M) vs CTMX (6.89M). CTMX has higher revenues than AMLX: CTMX (141M) vs AMLX (-249K).
AMLXCTMXAMLX / CTMX
Capitalization1.44B549M262%
EBITDA-196.3M44.7M-439%
Gain YTD256.878223.301115%
P/E Ratio2.696.6640%
Revenue-249K141M-0%
Total Cash181M158M115%
Total Debt5.96M6.89M87%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXCTMX
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGFIX14.22N/A
N/A
William Blair Growth I
JAGRX64.75N/A
N/A
Janus Henderson VIT Research Instl
UBVRX82.14N/A
N/A
Undiscovered Managers Behavioral Val R2
GSAEX29.75N/A
N/A
Goldman Sachs China Equity Inv
BMSFX15.55N/A
N/A
MFS Blended Research Mid Cap Eq A